drugset / Trial / NCT01684969
Evidence of Haloperidol Absorption After Topical Administration
RandomizedCrossoverTriple-blindTreatment
Summary
This will be a blinded study to compare the absorption of topical haloperidol with placebo
Timeline
- Start
- 2012-03
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 0.5 mg | Intravenous |
Indications
No indication recorded.